209 Davis ME, Zuckerman JE, Choi CHJ, Seligson D, Tolcher A, Alabi CA, Yen Y, Heidel JD, Ribas A
What GLP-1 programs have no subscription or membership fee
Mounjaro generated $8.66 billion (+125% YoY) and Zepbound delivered $4.16 billion (+80% YoY)
FIGURE 6 In patients with obesity but without diabetes (OB+/DM), no significant changes in longitudinal muscle contraction were observed following incubation with either GLP-1 (78.87% 30.47%, n = 6) or GIP (66.20% 22.02%, n = 6) when compared to control (84.38% 28.92%, n = 6
Health insurers can also proactively engage with patients to provide counselling on treatment, administration, and possible side effects